Lv3
230 积分 2021-07-06 加入
Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
7天前
已完结
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
11天前
已完结
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
11天前
已完结
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
12天前
已完结
Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma
12天前
已完结
Immunotherapies for hepatocellular carcinoma
1个月前
已完结
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
1个月前
已关闭
超高危动脉粥样硬化性心血管疾病患者血脂管理中国专家共识
1个月前
已完结
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
1个月前
已完结
A Retrospective, Epidemiological Review of Type 2 Diabetes Mellitus in a Military Population
2个月前
已关闭
皖公网安备34019202002308
